Researchers at King's College London have developed IgE antibodies targeting HER2-expressing cancers. Early studies show ...
Dr. Kevin Kalinsky covers the gamut of the current treatment landscape for patients with HER2-negative breast cancer, ...
Novel HER2 therapies show strong intracranial efficacy, enabling systemic treatment over local therapy for small, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback